Selpercatinib and Pseudo-Decreases in Kidney Function
Hassan Izzedine, Élise Bouderlique, Benjamin Besse
Abstract
Selpercatinib leads to pseudo-decreased kidney function, which impairs tubular creatinine excretion. Cystatin C has no tubular secretion and may be a better marker for managing selpercatinib treatment.
Topics & Concepts
Function (biology)Renal functionMedicineInternal medicineBiologyCell biologyRenal cell carcinoma treatmentPI3K/AKT/mTOR signaling in cancerCancer Mechanisms and Therapy